TAK-020
TAK-020 is a covalent Btk inhibitor, which becomes the clinical candidate.
Product Specifications
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tak-020.html
Purity
99.93
Solubility
DMSO : 20.83 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
O=C1NNC(C2=CC3=C(C(O[C@@H]4CN(C(C=C)=O)CC4)=N2)C=CC=C3)=N1
Molecular Formula
C18H17N5O3
Molecular Weight
351.36
References & Citations
[1]Sabat M, et al. Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 (S) -5- (1- ((1-Acryloylpyrrolidin-3-yl) oxy) isoquinolin-3-yl) -2,4-dihydro-3H-1,2,4-triazol-3-one, by Fragment-Based Drug Design. J Med Chem. 2021 Sep 9;64 (17) :12893-12902.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-132879/TAK-020-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-132879/TAK-020-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
Phase 1
CAS Number
[1627603-21-7]
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
IRBAHUDPH7AAP235120UL 120 µL
Rabbit Anti Human DPH7 Polyclonal Antigen affinity Purified (PBS with 0.05% NaN3 and 40% Glycerol, pH7.4) (IHC,ELISA) 120ul
Ask
View Details 
